Search Results - "Richardet, Martin Eduardo"

Analysis of the LIPI score as a prognostic factor in advanced non-small cell lung cancer by Richardet, Eduardo, Perea, Pablo, Molina, Matias, Magi, Ignacio, Depetris, Santos, Richardet, Martin Eduardo

“…e20612 Background: A field of interest is the search for new biomarkers within which inflammatory/immunological ones have taken on special relevance. The LIPI…”
Get full text

Analysis of the relationship between different prognosis factors in patients with advanced colon cancer and progression-free survival by Richardet, Eduardo, Magi, Ignacio, Acosta, Luciana Paola, Ferreira, Maria gimena, Molina, Matias, Richardet, Martin Eduardo

“…Abstract only e15518 Background: Colon tumors are a heterogeneous group of disease. As a result of the accumulation of different genetic and epigenetic…”
Get full text

Neutrophil-lymphocyte radio (NLR) as a possible predictive factor in patients with advanced NSCLC WHO received immunotherapy by Richardet, Eduardo, Acosta, Luciana Paola, Ferreira, Maria gimena, Magi, Ignacio, tello Alfonso, Rocio, Molina, Matias, Richardet, Martin Eduardo

“…Abstract only e21042 Background: There exists a strong relationship between cancer and inflammation. For this reason, attempts have been made to identify…”
Get full text

Relationship between neutrophils/lymphocytes and tumor infiltrating lymphocytes stroma in patients with invasive muscle bladder cancer and the response to treatment by Richardet, Martin Eduardo, Ferreira, Maria gimena, Paradelo, Martin, Acosta, Luciana Paola, Molina, Matias, Magi, Ignacio, Richardet, Eduardo

“…Abstract only e16513 Background: The bladder cancer is a malignant disease. It has been related to tobacco consumption, fat diet, high body mass index (BMI)…”
Get full text

Analysis of lymphocyte-neutrophil relationship in patients with advanced kidney cancer and the response to one-line treatment with target therapies by Acosta, Luciana Paola, Richardet, Martin Eduardo, Molina, Matias, Richardet, Eduardo

“…Abstract only e23034 Background: In kidney cancer, some important prognostic factors of survival are known and inflammation plays a key role. It has been…”
Get full text

Lympho-platelets relationship as a prognostic factor for advanced colorectal cancer by Richardet, Eduardo, Villavicencio, Rocio Paola, Acosta, Luciana Paola, Molina, Matias, Dicalbo, Luciano, Richardet, Martin Eduardo

“…Abstract only…”
Get full text

Safety of darolutamide (DARO) for nonmetastatic castration-resistant prostate cancer (nmCRPC) from extended follow-up in the phase III ARAMIS trial by Smith, Matthew Raymond, Fizazi, Karim, Tammela, Teuvo L. J., Cruz, Felipe Melo, Nordquist, Luke T., Aleman Polanco, Diana Sofia, Emmenegger, Urban, Silveira, Glauco Costa, Concepcion, Raoul S., Paula, Adriano, de Mendonça Beato, Carlos Augusto, Fleshner, Neil, Richardet, Martin Eduardo, Kuss, Iris, Le Berre, Marie-Aude, Borghesi, Gustavo, Sarapohja, Toni, Shore, Neal D.

“…Abstract only 239 Background: DARO is a structurally distinct androgen receptor inhibitor (ARI) approved for treating nmCRPC. In ARAMIS, DARO significantly…”
Get full text

Nivolumab + cabozantinib (NIVO+CABO) versus sunitinib (SUN) for advanced renal cell carcinoma (aRCC): Outcomes by sarcomatoid histology and updated trial results with extended follow-up of CheckMate 9ER by Motzer, Robert J., Choueiri, Toni K., Powles, Thomas, Burotto, Mauricio, Bourlon, Maria Teresa, Hsieh, James J, Maruzzo, Marco, Shah, Amishi Yogesh, Suarez, Cristina, Barrios, Carlos H., Richardet, Martin Eduardo, Porta, Camillo, Goh, Jeffrey C., Tomita, Yoshihiko, Bedke, Jens, Zhang, Joshua, Simsek, Burcin, Scheffold, Christian, Gupta, Saurabh, Apolo, Andrea B.

“…Abstract only 308 Background: First-line NIVO+CABO met primary and secondary efficacy endpoints by improving progression-free survival (PFS; HR 0.51, P <…”
Get full text

A randomized, multicenter clinical trial to determine the efficacy and safety of pegfilgrastim (GEMA BIOTECH) compared to pegfilgrastim (Roche) for prevention of chemotherapy induced neutropenia in patients with breast cancer by Richardet, Martin Eduardo, Kowalyszyn, Ruben Dario, Varela, Mirta Susana, Ortiz, Eduardo, Micheri, Cristian, Zarba, Juan Jose, Kahl, Susana, Klimovsky, Ezequiel, Federico, Andrea Alicia, Fein, Luis Enrique, Cassini, Jorge Horacio, Cortese, Gustavo, Visintini Jaime, Florencia, Cordeiro, Lucas, Lago, Nestor Ruben

“…Abstract only 3113 Background: Peg-Neutropine, GEMA BIOTECH SAU biosimilar Peg-Filgrastim, is the first Peg-Filgrastim approved in LATAM for prevention of…”
Get full text

Final analysis of the CheckMate 025 trial comparing nivolumab (NIVO) versus everolimus (EVE) with >5 years of follow-up in patients with advanced renal cell carcinoma (aRCC) by Motzer, Robert J., Tykodi, Scott S., Escudier, Bernard, Oudard, Stephane, Hammers, Hans J., McDermott, David F., George, Saby, Castellano, Daniel, Choueiri, Toni K., Alva, Ajjai Shivaram, Richardet, Martin Eduardo, Plimack, Elizabeth R., Srinivas, Sandy, Procopio, Giuseppe, Donskov, Frede, Gurney, Howard, Tomita, Yoshihiko, McHenry, M. Brent, Saggi, Shruti Shally, Tannir, Nizar M.

“…Abstract only 617 Background: CheckMate 025 demonstrated superior overall survival (OS) in previously treated patients (pts) with aRCC, with improved safety…”
Get full text

Multicenter observational study of temsirolimus use records conducted under conditions of routine medical practice by Richardet, Martin Eduardo, Sala, Raul, Fein, Luis, Richardet, Eduardo Arnoldo

“…Abstract only e15610 Background: Sometimes efficacy and toxicity reported in clinical trials differs from what is later found on everyday practice…”
Get full text

Tumor-infiltrating lymphocytes as a prognostic factor in patients with stage I to III breast cancer by Richardet, Eduardo, Acosta, Luciana Paola, Paradelo, Martin, Pairola, Martin, Di Tada, Cecilia, Molina, Matias, Dicalbo, Luciano Salvador, Villavicencio, Rocio Paola, Richardet, Martin Eduardo

“…Abstract only e12042 Background: Current evidence makes reference to the potential role that tumor-infiltrating lymphocytes (TILs) as a prognostic factor in…”
Get full text

Relationship between tumor infiltrating lymphocytes (Tils) and neutrophil-lymphocyte ratio (NLR) as a prognostic factor in patients with advanced non-small cell lung cancer by Richardet, Eduardo, Hernandez, Patricia Andrea, Richardet, Martin Eduardo, Cortes, Matias Nicolas, Molina, Matias, Acosta, Luciana Paola, Dicalbo, Luciano, Villavicencio, Rocio, Pets, Evelin, Paradelo, Martin

“…Abstract only…”
Get full text

Analysis of the state of lymphocyte infiltration in patients with NSCLC by Richardet, Eduardo, Richardet, Martin Eduardo, Hernandez, Patricia Andrea, Riso, Aldo Alejandro, Cortes, Matias Nicolas, Molina, Matias, Pacher, Eugenia, Companys, Pablo, Acosta, Luciana Paola, Dicalbo, Luciano Salvador

“…Abstract only…”
Get full text

Association between the expression of hormone receptors and HER2/Neu in early breast cancer and overweight or obesity by Richardet, Eduardo, Richardet, Martin Eduardo, Molina, Matias, Cortes, Matias Nicolas, Brombin, Romina, Riso, Aldo Alejandro, Companys, Pablo, Acosta, Luciana Paola, Hernandez, Patricia

“…Abstract only…”
Get full text

Number of cycles of chemotherapy in patients with advanced non-small cell lung caner: Efficacy and relationship with histology by Richardet, Eduardo, Richardet, Martin Eduardo, Castagneris, Nicolas, Cortes, Matias Nicolas, Laura, Perelli, Molina, Matias

“…Abstract only e18125 Background: Platinum based regimens are standard first-line treatment in patients with advanced non mall cell lung cancer. We intend to…”
Get full text

Concomitant chemoradiotherapy in women with stage II-III breast cancer by Richardet, Eduardo arnoldo, Laura, Perelli, Richardet, Martin Eduardo, Castagneris, Nicolas, Cortes, Matias Nicolas, Molina, Matias

“…Abstract only e11501 Background: To demonstrate the compliance of radiotherapy and chemotherapy with concomitant taxanes by avoiding delays initiation of that…”
Get full text

Relationship between obesity and survival in advanced breast cancer by Castagneris, Nicolas, Cortes, Matias Nicolas, Richardet, Eduardo, Richardet, Martin Eduardo, Laura, Perelli, Molina, Matias

“…Abstract only e11044 Background: Breast cancer is the second cause of cancer-related deaths. Obesity is defined as an excessive accumulation of fat. The body…”
Get full text

Treatment beyond progression with nivolumab (nivo) in patients (pts) with advanced renal cell carcinoma (aRCC) in the phase III CheckMate 025 study by Escudier, Bernard J., Motzer, Robert J., Sharma, Padmanee, Wagstaff, John, Plimack, Elizabeth R., Hammers, Hans J., Donskov, Frede, Gurney, Howard, Sosman, Jeffrey Alan, Zalewski, Pawel, Harmenberg, Ulrika, McDermott, David F., Choueiri, Toni K., Richardet, Martin Eduardo, Tomita, Yoshihiko, Ravaud, Alain, Doan, Justin, Zhao, Huanyu, Hardy, Helene, George, Saby

“…Abstract only…”
Get full text